Literature DB >> 3394681

Single- vs double-lumen central venous catheters in pediatric oncology patients.

R J Shulman1, E O Smith, S Rahman, P Gardner, T Reed, D Mahoney.   

Abstract

Double-lumen central venous catheters (CVCs) have been introduced recently for use in pediatric patients. The objective of our study was to determine if double-lumen CVC usage increased the possibility of infectious and mechanical complications compared with that of traditional single-lumen CVCs in a population at high risk for infection (oncology patients). Thirty pediatric patients (2.5 +/- 3.0 years old; mean +/- SD) who received single-lumen CVCs were compared with 31 patients (5.9 +/- 4.7 years old) who received double-lumen CVCs. The incidence of infectious complications was compared while controlling for potential confounding variables. Fifty-seven percent (17/30) of patients in the single-lumen group experienced bacteremia or cellulitis that required removal of six catheters compared with a rate of 52% (16/31) and nine catheter removals in the double-lumen group. Fewer manipulations occurred in the single-lumen group compared with the double-lumen group, but the incidence of mechanical complications tended to be greater. When managed carefully, double-lumen CVCs were not associated with a greater risk of infection than single-lumen CVCs.

Entities:  

Mesh:

Year:  1988        PMID: 3394681     DOI: 10.1001/archpedi.1988.02150080099034

Source DB:  PubMed          Journal:  Am J Dis Child        ISSN: 0002-922X


  5 in total

1.  Intervention to reduce catheter-related bloodstream infections in a pediatric intensive care unit.

Authors:  Corsino Rey; Francisco Alvarez; Victoria De-La-Rua; Andrés Concha; Alberto Medina; Juan-José Díaz; Sergio Menéndez; Marta Los-Arcos; Juan Mayordomo-Colunga
Journal:  Intensive Care Med       Date:  2011-01-27       Impact factor: 17.440

2.  epic3: national evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  H P Loveday; J A Wilson; R J Pratt; M Golsorkhi; A Tingle; A Bak; J Browne; J Prieto; M Wilcox
Journal:  J Hosp Infect       Date:  2014-01       Impact factor: 3.926

3.  Totally implantable vascular access devices in 131 pediatric oncology patients.

Authors:  J E Sola; M M Stone; P M Colombani
Journal:  Pediatr Surg Int       Date:  2013-09-21       Impact factor: 1.827

4.  epic2: National evidence-based guidelines for preventing healthcare-associated infections in NHS hospitals in England.

Authors:  R J Pratt; C M Pellowe; J A Wilson; H P Loveday; P J Harper; S R L J Jones; C McDougall; M H Wilcox
Journal:  J Hosp Infect       Date:  2007-02       Impact factor: 3.926

Review 5.  Vascular Access in Pediatric Oncology and Hematology: State of the Art.

Authors:  Alessandro Crocoli; Cristina Martucci; Giorgio Persano; Maria Debora De Pasquale; Annalisa Serra; Antonella Accinni; Ivan Pietro Aloi; Arianna Bertocchini; Simone Frediani; Silvia Madafferi; Valerio Pardi; Alessandro Inserra
Journal:  Children (Basel)       Date:  2022-01-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.